EU Bodies Back Mix-And-Match Approach For COVID-19 Boosters
Heterologous Vaccine Regimens Give More Flexibility
New advice on the use of "mix-and-match" primary and booster vaccine regimens has been published by the EMA and the ECDC, while a new CEPI-supported clinical trial will test heterologous booster combinations involving Medigen’s COVID-19 vaccine and other jabs.
